This page collects WhisperX intelligence signals tagged #Grünenthal. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
A high-stakes acquisition battle is forming over Organon & Co., the New York-listed women's healthcare specialist. According to people familiar with the matter, India's pharmaceutical titan Sun Pharmaceutical Industries Ltd. and Germany's Grünenthal are among the firms actively vying for the company. This positions Org...
Organon's stock price is climbing on market speculation that the pharmaceutical company has become a target for potential acquisition. Reports indicate that two major players, India's Sun Pharmaceutical Industries and Germany's Grünenthal, are actively exploring takeover deals for the women's health and biosimilars-foc...